Skip to main content
Camp4 Therapeutics Corp logo

Camp4 Therapeutics Corp — Investor Relations & Filings

Ticker · CAMP ISIN · US13463J1016 US Manufacturing
Filings indexed 142 across all filing types
Latest filing 2025-03-18 Regulatory Filings
Country US United States of America
Listing US CAMP

About Camp4 Therapeutics Corp

https://www.camp4tx.com/

Camp4 Therapeutics Corp. is a clinical-stage biopharmaceutical company that develops programmable therapeutics for a range of genetic diseases. The company pioneers an approach centered on regulatory RNA (regRNA) to modulate gene expression and amplify the production of healthy proteins. Its core technology involves RNA Actuators, a class of antisense oligonucleotides (ASOs), which are designed to restore protein levels to a healthy range. Camp4 utilizes its proprietary RNA Actuating Platform (RAP) to discover and advance its pipeline of potential disease-modifying treatments, with a focus on rare genetic conditions where upregulating protein expression may offer therapeutic benefits.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2025-03-18 English
FORM 8-K
Regulatory Filings
2025-01-07 English
10-Q
Interim / Quarterly Report Q3 2024
2024-11-21 English
FORM 8-K
Regulatory Filings
2024-11-21 English
SC 13G
Major Shareholding Notification
2024-10-23 English
SC 13D
Major Shareholding Notification
2024-10-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.